Immune Derangements in Patients with Myelofibrosis: The Role of Treg, Th17, and sIL2Rα
Myelofibrosis (MF), including primary myelofibrosis, post-essential thrombocythemia MF, and post-polycythemia vera MF, has been reported to be associated with autoimmune phenomena. IMiDs have been reported to be effective in some patients with MF, presumably for their immune-modulator effects. We th...
Main Authors: | Wang, Jen C., Sindhu, Hemant, Chen, Chi, Kundra, Ajay, Kafeel, Muhammad I., Wong, Ching, Lichter, Stephen |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368690/ |
Similar Items
-
Increased Th17/Treg Ratio in Poststroke Fatigue
by: Liu, Xinjing, et al.
Published: (2015) -
The Expression of Notch/Notch Ligand, IL-35, IL-17, and Th17/Treg in Preeclampsia
by: Cao, Weiping, et al.
Published: (2015) -
The Dynamics of Treg/Th17 and the Imbalance of Treg/Th17 in Clonorchis sinensis-Infected Mice
by: Yan, Chao, et al.
Published: (2015) -
Treg/IL-17 Ratio and Treg Differentiation in Patients with COPD
by: Jin, Yang, et al.
Published: (2014) -
Th17 and Treg Cells in Bone Related Diseases
by: Wang, Min, et al.
Published: (2013)